Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exercise Tolerance After Venous Recanalization for Post-thrombotic Syndrome: ETERecaVSPT

NCT05794932 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05794932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05794932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exercise Tolerance After Venous Recanalization for Post-thrombotic Syndrome: ETERecaVSPT
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
April 17, 2023
Completion date
May 15, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

claudication, intermittent, post thrombotic syndrome, venous thromboses